ZOM has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ZOM has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-05-28), Zomedica's current share price is $0.1744. Zomedica's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $0.13. Zomedica's Cyclically Adjusted PB Ratio for today is 1.34.
The historical rank and industry rank for Zomedica's Cyclically Adjusted PB Ratio or its related term are showing as below:
During the past years, Zomedica's highest Cyclically Adjusted PB Ratio was 1.97. The lowest was 0.95. And the median was 1.44.
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.
Zomedica's adjusted book value per share data for the three months ended in Mar. 2024 was $0.237. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.13 for the trailing ten years ended in Mar. 2024.
The historical data trend for Zomedica's Cyclically Adjusted PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zomedica Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Cyclically Adjusted PB Ratio | Get a 7-Day Free Trial | 1.89 | 1.72 | 1.38 | 1.63 | 1.15 |
For the Medical Devices subindustry, Zomedica's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Zomedica's Cyclically Adjusted PB Ratio distribution charts can be found below:
* The bar in red indicates where Zomedica's Cyclically Adjusted PB Ratio falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.
Zomedica's Cyclically Adjusted PB Ratio for today is calculated as
Cyclically Adjusted PB Ratio | = | Share Price | / | Cyclically Adjusted Book per Share |
= | 0.1744 | / | 0.13 | |
= | 1.34 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zomedica's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:
For example, Zomedica's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:
Adj_Book | = | Book Value per Share | / | CPI of Mar. 2024 (Change) | * | Current CPI (Mar. 2024) |
= | 0.237 | / | 131.7762 | * | 131.7762 | |
= | 0.237 |
Current CPI (Mar. 2024) = 131.7762.
Zomedica Quarterly Data
Book Value per Share | CPI | Adj_Book | |
201405 | 0.113 | 100.373 | 0.148 |
201408 | 0.107 | 100.352 | 0.141 |
201411 | 0.097 | 99.635 | 0.128 |
201502 | 0.078 | 99.032 | 0.104 |
201505 | 0.073 | 100.333 | 0.096 |
201508 | 0.066 | 100.548 | 0.086 |
201511 | 0.052 | 100.135 | 0.068 |
201602 | 0.042 | 100.040 | 0.055 |
201606 | 0.026 | 101.688 | 0.034 |
201609 | 0.059 | 101.861 | 0.076 |
201612 | 0.046 | 101.863 | 0.060 |
201703 | 0.033 | 102.862 | 0.042 |
201706 | 0.048 | 103.349 | 0.061 |
201709 | 0.069 | 104.136 | 0.087 |
201712 | 0.049 | 104.011 | 0.062 |
201803 | 0.040 | 105.290 | 0.050 |
201806 | 0.050 | 106.317 | 0.062 |
201809 | 0.031 | 106.507 | 0.038 |
201812 | 0.037 | 105.998 | 0.046 |
201903 | -0.017 | 107.251 | -0.021 |
201906 | -0.040 | 108.070 | -0.049 |
201909 | -0.064 | 108.329 | -0.078 |
201912 | -0.091 | 108.420 | -0.111 |
202003 | -0.078 | 108.902 | -0.094 |
202006 | 0.049 | 108.767 | 0.059 |
202009 | 0.073 | 109.815 | 0.088 |
202012 | 0.080 | 109.897 | 0.096 |
202103 | 0.285 | 111.754 | 0.336 |
202106 | 0.282 | 114.631 | 0.324 |
202109 | 0.277 | 115.734 | 0.315 |
202112 | 0.276 | 117.630 | 0.309 |
202203 | 0.275 | 121.301 | 0.299 |
202206 | 0.272 | 125.017 | 0.287 |
202209 | 0.274 | 125.227 | 0.288 |
202212 | 0.273 | 125.222 | 0.287 |
202303 | 0.268 | 127.348 | 0.277 |
202306 | 0.265 | 128.729 | 0.271 |
202309 | 0.266 | 129.860 | 0.270 |
202312 | 0.245 | 129.419 | 0.249 |
202403 | 0.237 | 131.776 | 0.237 |
Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.
Thank you for viewing the detailed overview of Zomedica's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Johnny D Powers | director | C/O ZOMEDICA CORP., 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR MI 48018 |
Heaton Larry C Ii | officer: President | C/O ZOMEDICA CORP., 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR MI 48018 |
Russell Kevin Klass | officer: Vice President of Sales | C/O ZOMEDICA CORP, PHOENIX DRIVE, SUITE 125, ANN ARBOR MI 48108 |
Peter Donato | officer: Chief Financial Officer | 9172 ETON AVENUE, CHATSWORTH CA 91311 |
Pamela Nichols | director | 14841 EAST WILDCAT DR., SCOTTSDALE AZ 85262 |
Karen Dehaan-fullerton | officer: Chief Counsel and Secretary | C/O ZOMEDICA CORP, 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR MI 48018 |
Anthony K Blair | officer: Chief Operating Officer | NEOPROBE CORPORATION, 425 METRO PLACE NORTH #300, DUBLIN OH 43017 |
Adrian Lock | officer: VP and General Manager | C/O ZOMEDICA CORP, 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR MI 48018 |
Sean Whelan | director | C/O ZOMEDICA CORP., 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR MI 48108 |
Robert Cohen | officer: Interim CEO | C/O ZOMEDICA CORP., 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR MI 48108 |
Ann Cotter | officer: Chief Financial Officer & Sec. | C/O ZOMEDICA PHARMACEUTICALS CORP., 100 PHOENIX DRIVE, SUITE 180, ANN ARBOR MI 48108 |
Stephanie Morley | officer: COO & VP of Product Dev | C/O ZOMEDICA CORP., 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR MI 48108 |
Christopher Ross Macleod | director | C/O ZOMEDICA CORP., 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR MI 48018 |
Christopher Wolfenberg | director | C/O ZOMEDICA PHARMACEUTICALS CORP, 100 PHOENIX DRIVE, SUITE 180, ANN ARBOR MI 48108 |
Gerald Jr Solensky | director, 10 percent owner, officer: President and CEO | C/O ZOMEDICA PHARMACEUTICALS CORP., 100 PHOENIX DRIVE, SUITE 190, ANN ARBOR MI 48108 |
From GuruFocus
By ACCESSWIRE • 09-14-2023
By ACCESSWIRE • 11-28-2023
By ACCESSWIRE • 10-05-2023
By ACCESSWIRE • 08-08-2023
By ACCESSWIRE • 01-18-2024
By ACCESSWIRE ACCESSWIRE • 05-12-2023
By ACCESSWIRE • 08-04-2023
By ACCESSWIRE ACCESSWIRE • 05-13-2023
By ACCESSWIRE ACCESSWIRE • 04-18-2023
By ACCESSWIRE • 08-31-2023